Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies
Philipp Königshofer(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), David Bauer(Austrian Academy of Sciences), Ksenia Brusilovskaya(Austrian Academy of Sciences), Katharina Lampichler(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Gerald Timelthaler(Comprehensive Cancer Center Vienna), Lukas Hartl(Medical University of Vienna), Katharina Wöran(Medical University of Vienna), Philipp Schwabl(Austrian Academy of Sciences), Judith Stift(Medical University of Vienna), Merima Herac(Medical University of Vienna), Bernhard Robl(Universitätsklinik Balgrist), Bruno K. Podesser(Ludwig Boltzmann Institute for Cardiovascular Research), Maria Sibila(Comprehensive Cancer Center Vienna), Oleksandr Petrenko(Austrian Academy of Sciences), Benedikt Hofer(Austrian Academy of Sciences), Mattias Mandorfer(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Georg Oberhuber(Medical University of Vienna)
Cited by 52
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399